The pathogenesis of idiopathic pulmonary fibrosis (IPF) involves a complex interplay of cell
types and signaling pathways. Recurrent alveolar epithelial cell (AEC) injury may occur in …

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal interstitial lung disease. During
the past decade, novel pathogenic mechanisms of IPF have been elucidated that have …

Pulmonary fibrosis is a chronic interstitial lung disease that causes irreversible and
progressive lung scarring and respiratory failure. Activation of fibroblasts plays a central role …

Rationale: A prevailing paradigm recognizes idiopathic pulmonary fibrosis (IPF) originating
from various alveolar epithelial cell (AEC) injuries, and there is a growing appreciation of …

Fibrosis is the abnormal deposition of extracellular matrix, characterized by accumulation of
collagen and other extracellular matrix components, which causes organ dysfunction and …

Externalized histones erupt from the nucleus as extracellular traps, are associated with
several acute and chronic lung disorders, but their implications in the molecular …

Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease (ILD). Pulmonary
fibroblasts play an important role in the development of IPF. Emerging evidence indicates …

Ethnopharmacological relevance Stemona is a medicinal plant that has been used in China
for thousands of years to treat respiratory diseases such as cough and tuberculosis. The …

Pulmonary fibrosis is the result of various diseases with no satisfactory treatment
approaches. The exosome-mediated transfer of long noncoding RNAs (lncRNAs) has been …

Pulmonary fibrosis (PF) is a type of fatal respiratory diseases with limited therapeutic options
and poor prognosis. The chemokine CCL17 plays crucial roles in the pathogenesis of …